MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HP-11-0008776
Exalt Pharmaceuticals Private Limited - pharma in Faridabad, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.13 Cr
▼ 25% YoY
Net profit · FY 2025
₹4.35 Lakh
Net margin 3.8%
EBITDA · FY 2025
₹11.51 Lakh
EBITDA margin 10.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Exalt Pharmaceuticals Private Limited
Data last updated:
Exalt Pharmaceuticals Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100HR2014PTC053831. Its GSTIN is 02AADCE8253D1Z2 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bhola Nath Prasad Gupta and Veena Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1207A Sector – 37 Faridabad Hr, Haryana, India – 121003.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.13 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹4.35 Lakh (net margin 3.8%) and EBITDA of ₹11.51 Lakh (EBITDA margin 10.2%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 21% over five years.
As per MCA filings, the company has open charges of ₹75 Lakh on record.
Exalt Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0008776). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website exaltpharmaceuticals.com.
Company details
CIN U24100HR2014PTC053831
Registration Number 053831
Incorporation Date 24 November 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HP-11-0008776
Recognitions & Rankings of Exalt Pharmaceuticals
Contact details
Exalt Pharmaceuticals Private Limited's registered office is in Faridabad, Haryana. Its website is exaltpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1207A Sector – 37 Faridabad Hr, Haryana, India – 121003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Exalt Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Exalt Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Exalt Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Exalt Pharmaceuticals Private Limited, buy the company report.
Financials of Exalt Pharmaceuticals Private Limited
FY 2024 filings availableExalt Pharmaceuticals Private Limited reported revenue of ₹1.13 Cr (down 25% YoY) for FY 2025.
Revenue · FY 2025
₹1.13 Cr ▼ 25%
Net profit · FY 2025
₹4.35 Lakh margin 3.8%
EBITDA · FY 2025
₹11.51 Lakh margin 10.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 33%
5 years · compounded
▼ 21%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 16%
5 years · compounded
▼ 6%
Revenue has declined at a compounded annual rate (CAGR) of 21% over five years, including a 25% fall in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exalt Pharmaceuticals Private Limited, buy the company report.
Board of directors of Exalt Pharmaceuticals Private Limited
Exalt Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhola Nath Prasad Gupta Also directs: Ortal Fashion Private Limited, Panacea Multicon Private Limited, Gargill Infrastructure Private Limited and 5 more | Director | 24 Nov 2014 | 11 Years 11 Months | Current |
| Veena Gupta Also directs: Ortal Fashion Private Limited, Panacea Multicon Private Limited, Gargill Infrastructure Private Limited and 5 more | Director | 24 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Exalt Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cospex Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2024) | -11.0% | Manimajra, Chandigarh, India | |||
| Exalt Pharmaceuticals Private Limitedthis company | ₹1.13 Cr (FY 2025) | ₹4.35 Lakh | 3.8% | -25.0% | Faridabad, Haryana, India | |
| Myren Life Science India Private Limited | ₹1.13 Cr (FY 2021) | -64.0% | Hyderabad, Telangana, India | |||
| Servigen Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Wellyz Pharmaceutical Private Limited | ₹1.13 Cr (FY 2025) | 2.0% | Durgapur Mc, West Bengal, India | |||
| Ambiens Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 119.0% | Csa, Uttar Pradesh, India | |||
| Jenfer Biosciences Private Limited | ₹1.12 Cr (FY 2025) | -11.0% | Ambala Cantt, Haryana, India |
To see the full peer comparison of Exalt Pharmaceuticals Private Limited, buy the company report.
Auditor
Exalt Pharmaceuticals Private Limited is audited by MANISH KISHOR for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH KISHOR | FY 2023 | 509565 |
Shareholding
The shareholding of Exalt Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Exalt Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹75 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Mar 2015 | 10566590 | Canara Bank | ₹75 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Exalt Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exalt Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Exalt Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AADCE8253D1Z2 | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Exalt Pharmaceuticals Private Limited, buy the company report.
Recent activity
Exalt Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Bhola Nath Prasad Gupta was appointed as Director on 24 Nov 2014.
AGM
Exalt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Exalt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Canara Bank amounted to Rs. 75.00 Lakh with Charge ID 10566590 was registered on 11 Mar 2015.
Appointed
Bhola Nath Prasad Gupta was appointed as Director.
Appointed
Veena Gupta was appointed as Director.
Incorporation
24 Nov 2014
Exalt Pharmaceuticals Private Limited was registered on 24 Nov 2014 with Roc Delhi & aged 11 years 11 months as per MCA records.
Frequently asked questions
Exalt Pharmaceuticals is an active private limited company based in Faridabad, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2014 (12+ years old) and is registered under CIN U24100HR2014PTC053831.
Exalt Pharmaceuticals has 2 current directors:
- Bhola Nath Prasad Gupta - Director
- Veena Gupta - Director
The latest financial statements of Exalt Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Exalt Pharmaceuticals is 02AADCE8253D1Z2, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Exalt Pharmaceuticals is U24100HR2014PTC053831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exalt Pharmaceuticals was incorporated on 24 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Exalt Pharmaceuticals by revenue are Cospex Pharmaceuticals Private Limited, Myren Life Science India Private Limited, Servigen Pharmaceuticals Private Limited, Wellyz Pharmaceutical Private Limited, Ambiens Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Bhola Nath Prasad Gupta was appointed as Director on 24 Nov 2014. Veena Gupta was appointed as Director on 24 Nov 2014.
Yes, Exalt Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-11-0008776).
Exalt Pharmaceuticals can be reached through the website exaltpharmaceuticals.com. Its registered office is in Faridabad, Haryana, India.
The registered office of Exalt Pharmaceuticals is at 1207A Sector – 37 Faridabad Hr, Haryana, India – 121003.